$174.62
+4.74%
Short interest
Short % of float
1.7%
Days to cover
3.7d
Shares short
17.70M
Vs Sep 15
+14%
Shorts are present, but a bounce here is mostly price, not a squeeze.
Why it's this high: the stock has been falling and shorts are still increasing. That is a bet the breakdown continues, not a fade of a spike.
Share count and days to cover are the latest FINRA settlement. Short % of float is from Finviz. Prints land about twice a month — fuel for a turn, not today's flow.
ARM Q3 earnings
Check guidance — raised = hold; lowered = review thesis
Next report
2027-02-02 · Q3 2027 (est.)
EPS est. 0.41 · actual 0.45 (+10.8%)
Last reported · 2026-06-30
Last surprise +10.8% vs estimate
Calendar earnings dates
ARM Q3 earnings
Check guidance — raised = hold; lowered = review thesis
Insider trades (Form 4)
Buys
444,033 sh
$77.5M
Sells
44,215 sh
$12.4M
Net (12 filings)
+399,818 sh
+$65.1M net
Child Jason (Open-market sale) — 10,400 sh · $3.1M
Abbey William (Stock award / grant) — 17,288 sh · $3.0M
Haas Rene A. (Stock award / grant) — 425,000 sh · $74.2M
Haas Rene A. (Stock award / grant) — 64 sh · $0.0M
Child Jason (Open-market sale) — 10,400 sh · $2.7M
Bartels Laura Kathleen (Option exercise) — 819 sh · $0.1M
Bartels Laura Kathleen (Option exercise) — 862 sh · $0.2M
Bartels Laura Kathleen (Tax withholding) — 856 sh · $0.2M
Bartels Laura Kathleen (Option exercise) — 819 sh · $0.1M
Bartels Laura Kathleen (Option exercise) — 862 sh · $0.2M
Sine Jeffrey (Gift) — 9,572 sh · $1.7M
Bartels Laura Kathleen (Open-market sale) — 11,306 sh · $4.4M
ARM Q1 FY25 earnings (est.)
Estimated — verify before trading
RSI, moving averages, MACD, Bollinger bands & candlestick patterns from Yahoo daily data — verify on chart
Below 20-day MA
Price $174.62 vs 20 SMA $218.52
Below 50-day MA
Price $174.62 vs 50 SMA $252.78
Below 200-day MA
Price $174.62 vs 200 SMA $230.83
Below 251-day high
-60.3% from 251-day high ($439.46)
Above 251-day low
67.0% above 251-day low ($104.55)
Hammer
Long lower wick on 2026-11-06 — potential reversal
Gap up
Opened 6.3% above prior close on 2026-11-06
Price vs 200-day EMA, plus whether profit shows up as cash. Cash flow, cash, capex growth, and interest coverage sit next to the multiple.
25.7% below 200-day EMA
26% below its 200-day EMA with solid revenue/margin/debt/FCF trends — technical discount on a fundamentally healthy company.
Trailing PE
218.0x
Invest rank
28
Swing rank
23
Earnings skew
open
Cash flow/share
—
Trailing twelve months
Cash/share
$3.38
Latest quarter
Interest cover
7.0x
Operating profit / interest
Price / FCF
174x
After capex
Rev / share
18.4%
Five-year revenue growth per share
Capex growth
28.4%
5-year rate
Gross margin
97.4%
Prior year 97.5%
Revenue growth
23.8%
YoY, TTM or latest quarter
Net margin
17.1%
TTM profitability
Debt / equity
0.2%
Lower = less leveraged
FCF growth
-2.3%
5Y CAGR, capex-aware
Composite fundamentals score: 71/100 · from Finnhub basic financials, verify against the latest 10-Q before acting.